Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours

BACKGROUND: RET plays an oncogenic role, and its aberrations are potentially actionable. However, they have seldom been reported in tumours other than lung or thyroid cancers. The correlation of RET aberrations with clinical characteristics, co-occurring aberrations, and responses to immune checkpoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, Chih-Chieh, Yeh, Yu-Min, Huang, Hsuan-Yi, Ting, Yu-Lin, Fu, Pei-An, Lin, Tzu-Chien, Liu, I-Ting, Yen, Chia-Jui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345067/
https://www.ncbi.nlm.nih.gov/pubmed/37347391
http://dx.doi.org/10.1007/s11523-023-00974-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345067/
https://www.ncbi.nlm.nih.gov/pubmed/37347391
http://dx.doi.org/10.1007/s11523-023-00974-6

Ejemplares similares